Andrew Huberman: Peptides, Sleep Tech, and the End of Obesity
Daisy Wolf speaks with Dr. Andrew Huberman, professor of neurobiology and ophthalmology at Stanford University and host of the Huberman Lab podcast. They discuss how the pandemic sparked a consumer health revolution, the emerging peptide and GLP landscape, what the science actually says about focus drugs, and the…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like The a16z Show →
🔬Beyond AlphaFold: How Boltz is Open-Sourcing the Future of Drug Discovery
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Andreessen Horowitz's Vijay Pande: "AI doctors"
How Risk Taking, Innovation & Artificial Intelligence Transform Human Experience | Marc Andreessen
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.